Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Triggering receptor expressed on myeloid cells (TREM‐2) is a membrane receptor associated with DAP12 that is expressed primarily in myeloid cells, including dendritic cells and microglia, and promotes fusion of osteoclast precursors into multinucleated cells. A rare autosomal recessive condition, Nasu‐Hakola disease (NHD) is associated with loss‐of‐function mutations in DAP12 and TREM‐2. The brain pathology observed in NHD patients suggests that disruption of the TREM‐2/DAP12 pathway leads to neurodegeneration with demyelination and axonal loss. In this study, we have characterized TREM‐2 protein expression on microglia using a newly produced monoclonal antibody directed against the mouse TREM‐2 receptor. We report that TREM‐2 expression is up‐regulated in the spinal cord during both the early inflammatory and chronic phases of myelin oligodendrocyte glycoprotein (MOG)35–55 peptide‐induced experimental autoimmune encaphalomyelitis (EAE). We also demonstrate that TREM‐2 is highly expressed on microglial cells in the central nervous system (CNS) during EAE and that blockade of TREM‐2 during the effector phase of EAE results in disease exacerbation with more diffuse CNS inflammatory infiltrates and demyelination in the brain parenchyma. These results demonstrate a critical role for TREM‐2 during inflammatory responses in the CNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies further support a role for microglia in the phagocytosis of myelin debris and potentially in subsequent axonal remyelination.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“TREM-2 is an important receptor involved in phagocytosis, and upon genetic absence or blockade of TREM-2, microglia fail to upregulate genes required for lipid metabolism and phagocytosis, resulting in the exacerbation of EAE [254, 255] (Table 6).”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“Indeed, in EAE it has been shown that TREM2 is upregulated in spinal cord microglia and that an anti-TREM2 antibody exacerbates disease172.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [172]
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Plat-E: an efficient and stable system for transient packaging of retroviruses
Morita, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
Self-citationAloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Self-citation
Cited by
Items 101–200 of 287
Walter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.704981 · Cited by 80
“It has been shown that soluble TREM1 competes with cell surface-bound TREM1 for ligands and thereby affects ligandinduced signaling (30, 31, 27).”
BackgroundResultSFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation
Rueda‐Carrasco, J., Martín‐Bermejo, M. J., Pereyra, G., Mateo, M. I., Borroto, A., Brosseron, F., Kummer, M. P., Schwartz, S., López‐Atalaya, J. P., Alarcón, B., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051696 · Cited by 82
“This shedding occurs, for example, in response to LPS-induced activation of TLR4 (Turnbull et al , 2006; Piccio et al , 2007), thereby attenuating micro-glial activation (Turnbull et al , 2006).”
Hernangomez, M., Carrillo-Salinas, F., Mecha, M., Correa, F., Mestre, L., Loria, F., Feliu, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
“CNS INNATE IMMUNE RESPONSE IN THE RESTORATION OF BRAIN HOMEOSTASIS: ROLE OF MICRO-”
Kaur, G., Rathod, S. S. S., Ghoneim, M. M., Alshehri, S., Ahmad, J., Mishra, A., & Alhakamy, N. A. (2022) · Biology · doi:10.3390/biology11010090 · Cited by 84
Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination
Thomas, L., & Pasquini, L. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00297 · Cited by 76
“Microglial TREM-2b expression is upregulated in inflammatory and chronic phases of EAE and produces disease exacerbation when blocked during the effector phase (Piccio et al., 2007).”
BackgroundThe Importance of NAD in Multiple Sclerosis
Penberthy, W., & Tsunoda, I. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185751 · Cited by 75
“Inhibition of TREM-2 exacerbates EAE [345].”
Geloso, M. C., & D’Ambrosi, N. (2021) · Cells · doi:10.3390/cells10030686 · Cited by 81
“Notably, both the course of the disease and brain inflammation are exacerbated when TREM2 expression is blockaded [115].”
BackgroundMicroglial diversity in neuropathic pain
Tsuda, M., Masuda, T., & Kohno, K. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.05.001 · Cited by 86
Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
Hoyos, H. C., Rinaldi, M., Mendez-Huergo, S. P., Marder, M., Rabinovich, G. A., Pasquini, J. M., & Pasquini, L. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.023 · Cited by 73
The immune response after hypoxia-ischemia in a mouse model of preterm brain injury
Albertsson, A.-M., Bi, D., Duan, L., Zhang, X., Leavenworth, J. W., Qiao, L., Zhu, C., Cardell, S., Cantor, H., Hagberg, H., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0153-z · Cited by 79
“multiple sclerosis (a white-matter disease) [44,45].”
HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFκB signaling axis
Periyasamy, P., Thangaraj, A., Bendi, V. S., & Buch, S. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.03.011 · Cited by 70
“Several studies have demonstrated that increased expression of miRNA-34a-signalling is associated with various neurological, neuroimmune, neuroinflammatory or neurodegenerative pathologies (Agostini et al., 2011b; Bhattacharjee et al., 2016; Boon et al., 2013; Gao et al., 2013; Junker et al., 2009; Kofman et al., 2013…”
BackgroundThe innate immune system in Alzheimer's disease
Boutajangout, A., & Wisniewski, T. (2013) · International Journal of Cell Biology · doi:10.1155/2013/576383 · Cited by 69
“In various models of multiple sclerosis increased microglial expression of TREM2 is associated with increased phagocytosis and a promotion of aM2-like activation state of microglia, which is thought to have protective effects [28, 29].”
BackgroundThe Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
Rosmus, D.-D., Lange, C., Ludwig, F., Ajami, B., & Wieghofer, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040840 · Cited by 67
“The importance of this pathway is underlined by the fact that TREM2-blockade in EAE exacerbates disease severity [103].”
BackgroundImmunohistochemical characterization of microglia in Nasu‐Hakola disease brains
Satoh, J., Tabunoki, H., Ishida, T., Yagishita, S., Jinnai, K., Futamura, N., Kobayashi, M., Toyoshima, I., Yoshioka, T., Enomoto, K., et al. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2010.01174.x · Cited by 66
“tis (EAE), and blockade of TREM2 enhances inflammatory demyelination during the effector phase of EAE.(30) The levels of TREM2 expression are elevated in microglia that accumulate around amyloid plaques in aged APP23 transgenic mice.”
BackgroundThe CNS mononuclear phagocyte system in health and disease
Mundt, S., Greter, M., & Becher, B. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.005 · Cited by 71
Sun, M., Zhu, M., Chen, K., Nie, X., Deng, Q., Hazlett, L. D., Wu, Y., Li, M., Wu, M., & Huang, X. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10938 · Cited by 66
Correale, C., Genua, M., Vetrano, S., Mazzini, E., Martinoli, C., Spinelli, A., Arena, V., Peyrin‐Biroulet, L., Caprioli, F., Passini, N., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.040 · Cited by 71
Self-citationModulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
Piccioni, G., Mango, D., Saidi, A., Corbo, M., & Nisticò, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052342 · Cited by 63
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63
“In experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, TREM2 expression in microglia was highly induced under inflammatory conditions and blocking TREM2 exacerbated inflammation and demyelination (Piccio et al., 2007).”
Woollacott, I. O. C., Nicholas, J. M., Heslegrave, A., Heller, C., Foiani, M. S., Dick, K. M., Russell, L. L., Paterson, R. W., Keshavan, A., Fox, N. C., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0405-8 · Cited by 62
Divergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB
Owens, R., Grabert, K., Davies, C. L., Alfieri, A., Antel, J. P., Healy, L. M., & McColl, B. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00056 · Cited by 54
“Studies using animal models of neurodegeneration have also suggested disease-modifying effects of TREM2 (Piccio et al., 2007; Jiang et al., 2014; Jay et al., 2015; Wang et al., 2015).”
BackgroundMethodThe triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
Genua, M., Rutella, S., Correale, C., & Danese, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0293-z · Cited by 68
“TREM-2 expression is up-regulated on microglia cells and infiltrating macrophages in both the spinal cord and brain during inflammatory burst [12], and myeloid cells transduced with TREM-2 dampen EAE in mice, by migrating to the CNS and releasing antiinflammatory cytokines [50].”
BackgroundGervois, P., & Lambrichts, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01668 · Cited by 57
“showed that inhibiting TREM2 activation is detrimental for EAE outcome (70).”
BackgroundMicroglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 61
Laflamme, N., Cisbani, G., Préfontaine, P., Srour, Y., Bernier, J., St-Pierre, M.-K., Tremblay, M.-È., & Rivest, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00178 · Cited by 55
Porrini, V., Lanzillotta, A., Branca, C., Benarese, M., Parrella, E., Lorenzini, L., Calzà, L., Flaibani, R., Spano, P., Imbimbo, B. P., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.029 · Cited by 60
TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages
Dabla, A., Liang, Y. C., Rajabalee, N., Irwin, C. L., Moonen, C. G. J., Willis, J. V., Berton, S., & Sun, J. (2022) · mBio · doi:10.1128/mbio.01456-22 · Cited by 62
“Necrosulfonamide (74), N-acetyl cysteine (NAC), and GSK2795039 were purchased from Millipore Sigma.”
MethodGao, S., Yi, Y., Xia, G., Yu, C., Ye, C., Tu, F., Shen, L., Wang, W., & Hua, C. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.07.008 · Cited by 56
Rohn, T. T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/860959 · Cited by 49
“In one study, blockade of TREM2 function enhanced disease progression in an experimental murine model of autoimmune encephalomyelitis [67].”
BackgroundDynamic Responses of Microglia in Animal Models of Multiple Sclerosis
Plastini, M. J., Desu, H. L., & Brambilla, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00269 · Cited by 48
“Indeed, inhibition of the LT beta receptor and suppression of TWEAK are both protective in cuprizone-induced demyelination (Plant et al., 2007; Iocca et al., 2008).”
BackgroundDeming, Y., Li, Z., Benitez, B. A., & Cruchaga, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1486823 · Cited by 48
Differential Modulation of TREM2 Protein during Postnatal Brain Development in Mice
Chertoff, M., Shrivastava, K., Gonzalez, B., Acarin, L., & Giménez-Llort, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072083 · Cited by 47
“Experiments defining TREM2 function after CNS pathology have shown that blockade of TREM2 in animal models of multiple sclerosis leads to disease exacerbation by increasing leukocyte infiltration and demyelination [42], while intravenous application of TREM2-transduced myeloid cells facilitated repair by reducing axon…”
BackgroundThe Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
Yaghmoor, F. (2014) · Journal of Alzheimer's Disease & Parkinsonism · doi:10.4172/2161-0460.1000160 · Cited by 47
“In several models of multiple sclerosis increased microglial expression of TREM2 has been shown to enhance phagocytosis and promotes a M2-like activation state of microglia, which is thought to have protective effects [46–48].”
BackgroundSinner, P., Peckert-Maier, K., Mohammadian, H., Kuhnt, C., Draßner, C., Panagiotakopoulou, V., Rauber, S., Linnerbauer, M., Haimon, Z., Royzman, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40370-2 · Cited by 47
Bambakidis, T., Dekker, S. E., Sillesen, M., Liu, B., Johnson, C. N., Jin, G., de Vries, H. E., Li, Y., & Alam, H. B. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4163 · Cited by 46
“40 The extrinsic pathway requires activation via a wide variety of ligands that are still poorly described.”
Microvesicles: What is the Role in Multiple Sclerosis?
Carandini, T., Colombo, F., Finardi, A., Casella, G., Garzetti, L., Verderio, C., & Furlan, R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00111 · Cited by 48
“Triggering receptor expressed on myeloid cells-2 (TREM2), a specific membrane-bound receptor involved in reducing inflammation and promoting phagocytosis, is increased in the CSF of both progressive and relapsing–remitting MS patients (24, 41, 44).”
BackgroundMicroglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Pinto, M. V., & Fernandes, A. M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175960 · Cited by 46
Radandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 43
Alzheimer’s disease: rare variants with large effect sizes
Del-Aguila, J. L., Koboldt, D. C., Black, K., Chasse, R., Norton, J., Wilson, R. K., & Cruchaga, C. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.008 · Cited by 41
Jiang, C. Q., Chen, Z., Wang, X., Zhang, Y., Guo, X., Fan, H., Huang, D., He, Y., Tang, X., Ai, Y., et al. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10081-y · Cited by 45
“Compelling evidences demonstrated that TREM2 plays crucial roles in immunemodulating of microglia and is closely related to microglia polarization (Zhai et al. 2017; Sanjay, Shin et al. 2022; Piccio et al. 2007).”
BackgroundKim, H., Walczak, P., Kerr, C., Galpoththawela, C., Gilad, A. A., Muja, N., & Bulte, J. W. M. (2012) · STEM CELLS · doi:10.1002/stem.1218 · Cited by 41
Martin, N. A., Nawrocki, A., Molnar, V., Elkjaer, M. L., Thygesen, E. K., Palkovits, M., Acs, P., Sejbaek, T., Nielsen, H. H., Hegedus, Z., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0202530 · Cited by 29
“In EAE, TREM2 is upregulated in microglia, and blocking TREM2 exacerbates disease [30].”
BackgroundFord, J. W., Gonzalez-Cotto, M., Macfarlane, A. W., Peri, S., Howard, O. M. Z., Subleski, J. J., Ruth, K. J., Haseebuddin, M., Al‐Saleem, T., Yang, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.662723 · Cited by 42
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Poppell, M., Hammel, G., & Ren, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065925 · Cited by 42
Belloli, S., Zanotti, L., Murtaj, V., Mazzon, C., Grigoli, G. D., Monterisi, C., Masiello, V., Iaccarino, L., Cappelli, A., Poliani, P. L., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1044-x · Cited by 40
“In MS, microglia activation seems to play a dual role, both favoring chronic inflammation and neurodegeneration through the modulation of T cells and release of reactive species, proteolytic enzymes, or other neurotoxic molecules [15, 16] and promoting re-myelination and oligodendrocyte differentiation [17].”
BackgroundHe, G., Luo, Z., Shen, T., Wang, Z.-Z., Li, P., Luo, X. G., Yang, J., Tan, Y., Wang, Y., Gao, P., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00591 · Cited by 39
“, 2007b) and the important protective functions of cell phenotype activation by microglial TREM2 (Piccio et al., 2007), we examined the levels of TREM2 expression and PI3K and Akt phosphorylation in EMF-stimulated N9 cells pretreated with HA.”
BackgroundMechanisms of remyelination: recent insight from experimental models
Tanaka, T., & Yoshida, S. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2014-0015 · Cited by 42
“Among the many phagocytic receptors involved in MS, triggering receptor expressed on myeloid cells-2 (TREM-2) is the best studied (50, 51).”
BackgroundPeluffo, H., Alí‐Ruiz, D., Ejarque‐Ortiz, A., Heras-Alvarez, V., Comas-Casellas, E., Martínez‐Barriocanal, Á., Kamaid, A., Álvarez‐Errico, D., Negro‐Demontel, M. L., Lago, N., et al. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00537.x · Cited by 35
“Very recently, it has been shown that the knockout mice for CD300f (mCD300f/CLM1) exhibits an increased neuropathology in response to the induction of EAE.”
BackgroundInfluentialHwang, M., Savarin, C., Kim, J., Powers, J., Towne, N., Oh, H., & Bergmann, C. C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02629-1 · Cited by 44
“Trem2 ablation impairs phagocytic activity of myeloid cells Numerous studies show that Trem2 is involved in the uptake and degradation of myelin debris, a process essential for remyelination [7, 8, 10].”
BackgroundResultInfluentialCavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 38
Microglia in the context of multiple sclerosis
Zhang, X., Chen, F., Sun, M., Wu, N., Liu, B., Yi, X., Ge, R., & Fan, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1157287 · Cited by 46
“Triggering receptor expressed on myeloid cells (TREM2), which is expressed on the cell surface and binds polyanions, thus activating downstream signaling cascades through the adapter DAP12 (also called TYRO protein tyrosine kinase binding protein) (67), has been found to be related to phagocytosis (68).”
BackgroundBelloli, S., Pannese, M., Buonsanti, C., Maiorino, C., Di Grigoli, G., Carpinelli, A., Monterisi, C., Moresco, R. M., & Panina-Bordignon, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.010 · Cited by 34
Self-citationScott‐Hewitt, N., Folts, C. J., Hogestyn, J. M., Piester, G., Mayer-Pröschel, M., & Noble, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx153 · Cited by 33
Whittaker, G. C., Orr, S. J., Quigley, L., Hughes, L., Francischetti, I. M. B., Zhang, W., & McVicar, D. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038398 · Cited by 33
Kawabori, M., Hokari, M., Zheng, Z., Kim, J. Y., Calosing, C., Hsieh, C. L., Nakamura, M. C., & Yenari, M. A. (2013) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2013.0020 · Cited by 32
“In an in vivo model of experimental autoimmune encephalo-myelitis, blockade of TREM2 using a monoclonal antibody led to the exacerbation of immune responses with increased de-myelination and worsened neurological function (Piccio et al. , 2007).”
Jiang, H., Si, Y., Li, Z., Huang, X., Chen, S., Zheng, Y., Xu, G. L., Chen, X., Chen, Y., Liu, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep38761 · Cited by 33
Microglia‐targeted stem cell therapies for Alzheimer disease: A preclinical data review
Shen, Z., Li, X., Bao, X., & Wang, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24066 · Cited by 35
“Microglia genetically modified to express TREM-2 are apt to acquire an alternatively activated phenotype and exhibit enhanced phagocytosis (Takahashi, Prinz, Stagi, Chechneva, & Neumann, 2007), whereas blockade of TREM-2 leads to diffuse CNS inflammation and demyelination (Piccio et al., 2007).”
Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease
Sfera, A., Gradini, R., Cummings, M., Diaz, E. L., Price, A. I., & Osorio, C. P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01062 · Cited by 34
“Indeed, TREM-2 blockade was demonstrated to exacerbate EAE and MS, linking this receptor to the CNS autoimmune disorders (99, 100).”
BackgroundFerrara, S. J., Chaudhary, P., DeBell, M. J., Marracci, G., Miller, H. I., Calkins, E., Pocius, E., Napier, B. A., Emery, B., BOURDETTE, D. N., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.07.014 · Cited by 37
Fernández, M., Baldassarro, V. A., Sivilia, S., Giardino, L., & Calzà, L. (2016) · Glia · doi:10.1002/glia.23025 · Cited by 31
“Also confirmed was the upregulation of TREM2, a membrane receptor expressed on microglial cells during EAE (Piccio et al., 2007), and CD40, associated with anti-inflammatory M2 microglia (Liu et al.”
BackgroundContributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases
Han, J., Wang, M., Ren, M., & Lou, H. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1264072 · Cited by 30
“microglia, exerting protective effects in MS mice [64,66], suggesting that TREM2 play a major role in MS.”
BackgroundMolecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Bhute, S., Sarmah, D., Datta, A., Rane, P., Shard, A., Goswami, A., Borah, A., Kalia, K., Dave, K. R., & Bhattacharya, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00104 · Cited by 35
Microglial carbohydrate-binding receptors for neural repair
Linnartz‐Gerlach, B., Bodea, L., & Neumann, H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1342-7 · Cited by 32
“If TREM2 is blocked via antibodies during the effector phase of EAE, a more severe disease course can be observed with an increase in diffuse CNS inflammatory infiltrates and more demyelination in the brain parenchyma (Piccio et al. 2007).”
BackgroundHeldmann, U., Mine, Y., Kokaia, Z., Ekdahl, C. T., & Lindvall, O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.005 · Cited by 32
“In mice with experimental autoimmune encephalitis (EAE), blockade of TREM-2 exacerbated the disease, while treatment with TREM-2-expressing myeloid cells reduced inflammation and improved the disease (Piccio, et al., 2007, Takahashi, et al., 2007).”
Fremuth, L. E., Hu, H., van de Vlekkert, D., Annunziata, I., Weesner, J. A., & d’Azzo, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115204 · Cited by 29
“26,43,59 However, few studies have focused on how posttranslational modifications affect Trem2 function.”
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk
Li, G., Sherchan, P., Tang, Z., & Tang, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210407150632 · Cited by 32
“TREM2 overexpression was found to be protective, partially caused by effects on clearance of myelin debris [65-67].”
BackgroundIncreased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis
Li, W., Chang, H., Wu, W., Xu, D., Jiang, M., Gao, J., Huang, Y., Xu, Y., Yin, L., & Zhang, X. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00062 · Cited by 52
Yoshida, O., Kimura, S., Dou, L., Matta, B. M., Yokota, S., Ross, M. A., Geller, D. A., & Thomson, A. W. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12757 · Cited by 27
“By contrast, blockade of TREM-2 exacerbates experimental autoimmune encephalitis (78).”
BackgroundDifferential Roles of TREM2+ Microglia in Anterograde and Retrograde Axonal Injury Models
Manich, G., Gómez‐López, A. R., Almolda, B., Villacampa, N., Recasens, M., Shrivastava, K., González, B., & Castellano, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.567404 · Cited by 28
Mayrhofer, F., Dariychuk, Z., Zhen, A., Daugherty, D. J., Bannerman, P. G. C., Hanson, A. M., Pleasure, D., Soulika, A. M., Deng, W., & Chechneva, O. V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105556 · Cited by 30
Chen, S., Wang, K., Zhao, J., Wu, W., Wu, Y., & Жао, Л. (2016) · Journal of Periodontal Research · doi:10.1111/jre.12417 · Cited by 26
“Contrary to TREM-1, TREM-2 is considered a negative regulator of inflammation, functioning not only during the early inflammation phase but also during the chronic phase (9).”
BackgroundTREM2+ macrophages: a key role in disease development
Wang, X., Wang, Y., Yang, L. X., Zhang, Y., & Yang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550893 · Cited by 43
“In addition to the aforementioned CNS degenerative diseases such as AD, TREM2-positive microglia also play a protective role in CNS in fl ammatory diseases such as experimental autoimmune encephalomyelitis (EAE) (20, 21) and multiple sclerosis (MS) (10).”
Savarin, C., Dutta, R., & Bergmann, C. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01325 · Cited by 28
“Similar to JHMV infection, TREM2 is predominantly expressed by microglia during EAE and cuprizone-induced demyelination (59) (60) (61) .”
BackgroundLi, P., Shen, T., Luo, X. G., Yang, J., Luo, Z., Tan, Y., He, G., Wang, Z., Yu, X., Wang, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92906-5 · Cited by 28
RetractedLin, C., Kong, Y., Chen, Q., Zeng, J., Pan, X., & Miao, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420731 · Cited by 27
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 24
Noble, M., Scott‐Hewitt, N., & Folts, C. J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.228712 · Cited by 23
“Engagement of Trem2 decreases inflammation, and blockade of Trem2 worsens disease progress in the experimental allergic encephalomyelitis (EAE) animal model of MS (Piccio et al., 2007).”
BackgroundThomas, K. A., King, R. G., Sestero, C. M., & Justement, L. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab1115-507r · Cited by 24
γ‐Secretase in microglia – implications for neurodegeneration and neuroinflammation
Walter, J., Kemmerling, N., Wunderlich, P., & Glebov, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14224 · Cited by 25
“Studies with TREM2 KO mice suggest that TREM2 has anti-inflammatory activity (Piccio et al. 2007; Colonna and Wang 2016).”
BackgroundJansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
“In the EAE model of MS, blocking TREM2 activity during the effector stage of the EAE model caused more severe pathological response and resulted in more diffuse demyelination pattern [113].”
BackgroundCurrent understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 25
Bénardais, K., Gudi, V., Gai, L., Nessler, J. N., Singh, V., Prajeeth, C. K., Skripuletz, T., & Stangel, M. (2014) · Glia · doi:10.1002/glia.22706 · Cited by 20
“In EAE, blockade of TREM 2 led to an exacerbation of disease (Piccio et al., 2007) whereas the injection of TREM 2 over-expressing myeloid cells resulted in the amelioration of EAE and increased myelin phagocytosis (Takahashi et al.”
BackgroundTREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 25
“…research showed that TREM2 exhibits high expression on microglia in the CNS during EAE, and TREM2 blockade during the effector phase of EAE exacerbates disease progression, diffuse CNS inflammatory infiltration, and demyelination, indicating TREM2’s critical role in CNS inflammatory response [149].”
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A. C., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02634-4 · Cited by 23
“Moreover, induction of CD11c + microglia by CSF1 has been associated with reduced demyelination in EAE [74] whereas blockade of CD11c + microglia is detrimental [52].”
BackgroundEvaluation of the relationship between TREM‐1/TREM‐2 ratio and clinical course in COVID‐19 pneumonia
Kerget, F., Kerget, B., Yılmaz, S. İ., & Kızıltunç, A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14697 · Cited by 21
Arcuri, C., Mecca, C., Giambanco, I., & Donato, R. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.04.005 · Cited by 20
Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson’s disease
Tan, T., Song, Z. J., Yuan, L., Xiong, W., Deng, X., Ni, B., Chen, Y., & Deng, H. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.029 · Cited by 18
Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson’s disease
He, S., Tan, T., Song, Z. J., Yuan, L., Deng, X., Ni, B., Chen, Y., & Deng, H. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.034 · Cited by 17
Understanding Microglia–Neuron Cross Talk: Relevance of the Microglia–Neuron Cocultures
Correa, F., Hernangómez, M., & Guaza, C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-520-0_20 · Cited by 18
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03120-9 · Cited by 18
“Moreover, TREM2 expression is up-regulated during EAE, and its blockade has been shown to exacerbate the severity of the disease [29].”
BackgroundSoluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS
Guo, T., Ma, J., Sun, J., Xu, W., Cong, H., Wei, Y., Ma, Y., Dong, Q., Kou, Y., Yin, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963373 · Cited by 19
“In addition, higher sTREM2 levels were observed in PACNS patients with poor outcomes, which is considered to be because of the weakening of the microglia functions of tissue repair, phagocytosis of dying cells, and control local inflammation, after shedding of TREM2, leading to damaging the functional impairment of th…”
BackgroundRole of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization
Qu, S., Hu, S., Xu, H., Wu, Y., Ming, S., Zhan, X., Wang, C., & Huang, X. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01094-x · Cited by 14
“In MS, the soluble myeloid trigger receptor-2 level is increased in cerebrospinal fluid (CSF) and is considered a new marker of microglial activation [33].”
Farzan, M., Rounkian, M. S., Rizi, A. A., Heidari, Z., Farzan, M., Fathi, M., Aghaei, A., Azadegan‐Dehkordi, F., & Bagheri, N. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115071 · Cited by 16
Rossi, M., Petralla, S., Protti, M., Baiula, M., Kobrlová, T., Soukup, O., Spampinato, S. M., Mercolini, L., Monti, B., & Bolognesi, M. L. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00375 · Cited by 14
Peña‐Ortega, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160928151546 · Cited by 18
“In a more specific manner, TREM-2 can be activated [366] or inhibited [367] by several”
Sanchez-Molina, P., Almolda, B., Benseny‐Cases, N., González, B., Perálvarez‐Marín, A., & Castellano, B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.015 · Cited by 14
Montalvo, V., Quigley, L., Vistica, B. P., Boelte, K. C., Nugent, L. F., Takai, T., McVicar, D. W., & Gery, I. (2013) · Immunology · doi:10.1111/imm.12158 · Cited by 12
TREM-2 negatively regulates LPS-mediated inflammatory response in rat bone marrow-derived MSCs
Ye, P., Xu, D., Xu, J., Liu, G., Huang, S. J., Zhang, W., Zheng, P., Li, J., & Huang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7212 · Cited by 14
Metadata
- Authors
- Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P.
- Affiliations
- University of Milan (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Panina‐Bordignon, Paola
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2007-04-19
- Volume
- 37
- Issue
- 5
- Pages
- 1290-1301
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2090134990
- Cited by
- 284
- References
- 51
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 13 · 2022: 25 · 2021: 20 · 2020: 17 · 2019: 14 · 2018: 21 · 2017: 16 · 2016: 17 · 2015: 14 · 2014: 27 · 2013: 17 · 2012: 9
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, DAP12, experimental autoimmune encephalomyelitis, microglia, demyelination, myelin oligodendrocyte glycoprotein, Nasu-Hakola disease, neuroinflammation, monoclonal antibodies, myeloid cells
- MeSH terms
- Animals, Brain, Encephalomyelitis, Autoimmune, Experimental, Fluorescent Antibody Technique, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, RNA, Messenger, Spinal Cord, Blotting, Northern, Up-Regulation, Microglia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.